Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags US: News LILLY DRN Business
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags US: News LILLY DRN Science
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Social issues Health & Science Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investment strategy Politics Markets
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Breaking News: Markets Novo Nordisk A/S Europe News
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Companies Amgen Inc Health care industry
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Companies Health care industry Business
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Novo Nordisk A/S Structure Therapeutics Inc Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Health care industry Companies Business News
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Health care industry Hims & Hers Health Inc Companies
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Stock Picks Novo Nordisk A/S stocks
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Social issues Hims & Hers Health Inc Health & Science
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Ford Motor Co International trade Teva Pharmaceutical Industries Ltd
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Health & Science Business Biotechnology
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Technology Internet Health care industry
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Health & Science Earnings Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Business News Europe Economy Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Science LILLY DRN Social issues
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Mad Money PepsiCo Inc/ Investment strategy
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags US: News Science LILLY DRN
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags LVMH Moet Hennessy Louis Vuitton SE Business Retail
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Health care industry Medicaid Novo Nordisk A/S
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Health & Science Social issues Johnson & Johnson
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Cigna Corp Breaking News: Technology Technology
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags GSK plc Ironwood Pharmaceuticals Inc Abbvie Inc
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Health & Science Business LILLY DRN
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.